课题基金 / 基金详情

Alzheimer's Disease Research Center at Columbia Univ.

Alzheimer's Disease Research Center at Columbia Univ.
哥伦比亚大学阿尔茨海默病研究中心。
批准号:
6896320
负责人:
MICHAEL L SHELANSKI
金额:
$211.97万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-06-15 至 2010-05-31

项目摘要

项目成果

MICHAEL L SHELANSKI的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):哥伦比亚大学的ADRC旨在推进和传播阿尔茨海默病和其他与年龄相关的神经退行性和痴呆疾病的病因、预防和治疗方面的知识。为此,我们维持和跟踪多民族和多种族的正常老年人和患有认知障碍的老年人患者人群,以确定疾病的自然历史作为年龄和基因组成的功能。在这个应用中,我们建议使用各种神经心理学,神经学和成像工具来检查AD的早期阶段,并在他们的一生中跟踪这些受试者。死亡时,将进行全面的神经病理学检查,并将疾病的临床、放射学和病理学观点联系起来。从这些受试者身上获得的组织和DNA将可用于该疾病的生物学和遗传学研究。ADRC的个别研究项目将研究AD的细胞和分子生物学的各个方面,以及使用MRI对人类受试者的大脑功能进行深入分析。在ADRC注册的患者将有机会参与痴呆症新药和治疗方法的试验。这些患者良好的认知状态使他们非常适合纳入临床试验。哥伦比亚ADRC的教育和信息核心致力于教育非专业人士和医学界关于阿尔茨海默病、最新研究进展和阿尔茨海默病患者护理的知识。ADRC为哥伦比亚大学内外的科学家提供资源,通过奖励试点拨款、提供组织和其他生物样本、提供对精心记录的患者群体的访问以及举办众多研讨会和临床病理相关会议,鼓励新的研究途径。遗传核心是adrc和adc家族招募和鉴定的主要组织者。遵从HIPAA的数据组织和统计咨询服务在ADRC下提供给哥伦比亚和它外部的研究社区。
英文摘要
DESCRIPTION (provided by applicant): The ADRC at Columbia seeks to advance and disseminate knowledge of the causes, prevention and treatment of Alzheimer's Disease and other age-related neurodegenerative and dementing disorders. Toward this end, we maintain and follow a multi-ethnic and multi-racial patient population of normal elderly and the elderly with cognitive disorders to establish the natural history of the disease as a function of age and of genetic makeup. In this application we propose to use a variety of neuropsychological, neurological and imaging tools to examine the earliest stages of AD and to follow these subjects throughout their lives. At death a comprehensive neuropathologic examination will be performed and the clinical, radiological and pathological views of the disease correlated. Tissues and DNA obtained from these subjects will be available for research on the biology and genetics of the disease. Individual research projects within the ADRC will examine various aspects of the cellular and molecular biology of AD as well as an in-depth analysis of brain function in human subjects using MRI. Patients enrolled in the ADRC will have the opportunity to participate in trials of new drugs and treatments for dementing diseases as they become available. The well-documented cognitive status of these patients makes them highly suitable for inclusion in clinical trials. The Education and Information Core of the Columbia ADRC endeavors to educate both lay and medical communities about AD, about the latest advances in research and about the care of the AD patient. The ADRC serves as a resource for scientists with Columbia as well as outside of it, encouraging new research avenues by the award of pilot grants, by providing tissues and other biological samples, by providing access to a carefully documented patient population and by numerous seminars and Clinical Pathological Correlation Conferences. The Genetics Core serves as the major organizer of family recruitment and identification across the ADRCs and ADCs. HIPAA compliant data organization and statistical consulting services are provided under the ADRC to the research community at Columbia and external to it.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Caspase-2 in Alzheimer's Disease
Targeting Caspase-2 in Alzheimer's Disease
Prospective Purification of Adult Stem Cell Astrocytes
Faculty recruitment on the Neurobiology of Aging
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究